ofa tirzepatide F.D.A. Approves New Obesity Drug That Will Compete With Wegovy Tirzepatide cuts diabetes risk by

GLP-1 released from diet & lifestyle strategies vs GLP-1 from medications The key difference to note is that the GLP-1 released via diet and lifestyle strategies stays active in the blood for significantly less time than the GLP-1 released via medications

Sign up for Market Briefs and get a 45-minute investing course thrown in for free.

These medications contain the active ingredient tirzepatide, which works similarly to semaglutide and other GLP-1s

Discover what we know about reta so far, when it might be available, and more

With food dysfunction: You flood the reward system with artificial dopamine hits receptors downregulate you need more food to feel anything meanwhile, non-food joys get quieter and quieter

In a major trial, patients using Zepbound lost an average of 20% of their body weight, while those using Semaglutide GLP-1 lost about 14%